Redmile Group, LLC Igm Biosciences, Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 3,072,478 shares of IGMS stock, worth $54.8 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
3,072,478
Previous 3,072,478
-0.0%
Holding current value
$54.8 Million
Previous $29.6 Million
28.81%
% of portfolio
1.38%
Previous 1.17%
Shares
5 transactions
Others Institutions Holding IGMS
# of Institutions
89Shares Held
21.4MCall Options Held
39.5KPut Options Held
16.5K-
Baker Bros. Advisors LP New York, NY4.09MShares$72.9 Million0.37% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.08MShares$72.7 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N43.33MShares$59.4 Million1.45% of portfolio
-
Goldman Sachs Group Inc New York, NY1.33MShares$23.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY883KShares$15.7 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $517M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...